BioSpace News Archive

Deals

Playing in the Hot Obesity Market, Carmot Braves Chilly IPO Waters

Armed with a pipeline of obesity and diabetes hopefuls, Carmot Therapeutics joins the small group of biotechs to attempt a Nasdaq debut this year.

November 20, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Outclassed by Eliquis, Bayer Halts Atrial Fibrillation Study of Factor XIa Inhibitor

Bayer’s investigational factor XIa inhibitor asundexian was inferior to BMS’ and Pfizer’s blockbuster blood thinner Eliquis (apixaban) in the Phase III OCEANIC-AF study.

November 20, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Next-Generation ADCs Strive to Overcome Toxicities, Payload Problems

As companies clamor for a piece of the antibody-drug conjugate pie, experts pose the question: is it possible to replicate the success of Enhertu?

November 20, 2023
·
5 min read
·
Hayley Shasteen
Drug Development

With New Phase III Data in Hand, Servier Eyes FDA Filing for Glioma Candidate

Vorasidenib decreased tumor volume by a mean of 2.5% every six months, compared to growth of 13.9% for placebo over the same time span. The candidate is also being tested in a regimen with Keytruda.

November 20, 2023
·
2 min read
·
Tristan Manalac
From the Bench to the Office: Advice for Graduate Students Considering Leaving Academia

A biopharma communications professional offers advice he wishes he’d received as a PhD student considering a career in industry.

November 20, 2023
·
11 min read
·
Ignacio Guerrero-Ros
NHS, Pharma Deal Doubles Annual Growth and Earmarks £400M for R&D

The new five-year deal will save the U.K.’s National Health Service an estimated £14 billion ($17.4 billion) and double the annual allowed growth in sales of branded medicines from 2% to 4% per year by 2027.

November 20, 2023
·
2 min read
·
Connor Lynch
Biologics Projected to Keep Gaining Ground in Cancer Therapeutics Market

The market size for biologic oncology therapies will reach $786 billion by 2029, far outstripping small molecules, a GlobalData report predicts.

November 20, 2023
·
4 min read
·
Patience Asanga
Bio NC

Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers third sales milestone payment for the region from Pfizer this year

Basilea Pharmaceutica Ltd announced that the continued strong sales performance of the antifungal Cresemba® by its license partner Pfizer Inc.

November 20, 2023
·
3 min read
Job Trends

Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASH

Novartis will present data from over 100 trials across its breast cancer and hematology portfolios at the 2023 San Antonio Breast Cancer Symposium and the American Society of Hematology Annual Meeting & Exposition.

November 20, 2023
·
8 min read
IRLAB to Present at ABGSC Investor Days on November 22, 2023

IRLAB Therapeutics AB announced that the company will present at the ABGSC Investor Days on Wednesday, November 22, 2023, in Stockholm, Sweden.

November 20, 2023
·
1 min read